EnhabitEHAB
EHAB
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
0.97% more ownership
Funds ownership: 94.04% [Q3] → 95.01% (+0.97%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]
0% less capital invested
Capital invested by funds: $374M [Q3] → $373M (-$314K) [Q4]
4% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 55
8% less funds holding
Funds holding: 178 [Q3] → 163 (-15) [Q4]
39% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 36
80% less call options, than puts
Call options by funds: $12K | Put options by funds: $59K
Research analyst outlook
We haven’t received any recent analyst ratings for EHAB.
Financial journalist opinion
Based on 6 articles about EHAB published over the past 30 days
Positive
Zacks Investment Research
6 days ago
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Positive
Zacks Investment Research
1 week ago
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock
Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Neutral
Business Wire
3 weeks ago
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit's dedication to providing high-quality, evidence-based care to older adults, ensuring their unique needs and preferences are consistently met. The Age-Friendly Health Systems initiative,.
Neutral
Seeking Alpha
3 weeks ago
Enhabit, Inc. (EHAB) Q4 2024 Earnings Call Transcript
Enhabit, Inc. (NYSE:EHAB ) Q4 2024 Results Conference Call March 6, 2025 10:00 AM ET Company Participants Jobie Williams - Senior Vice President and Treasurer Barb Jacobsmeyer - President and Chief Executive Officer Ryan Solomon - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Ryan Langston - TD Cowen Operator Hello, and welcome to the Enhabit Inc. Fourth Quarter 2024 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Jobie Williams, Enhabit's Senior Vice President and Treasurer.
Negative
Zacks Investment Research
3 weeks ago
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates
Enhabit (EHAB) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
Neutral
Business Wire
3 weeks ago
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. “Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments,” said Barb Jacobsmeyer, president and chief executive officer of Enhabit. “In our home health segment, fourth quarter Medicare census continued to stabilize, and with th.
Neutral
Business Wire
1 month ago
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit's 2025 annual meeting of stockholders. Chairman of the Board Jeff Bolton said, “We look forward to Steve joining us as a director and we believe our stockholders will agree that he brings strong, relevant industry expertise to our board. Steve's 25 years of executive-lev.
Positive
Zacks Investment Research
1 month ago
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum
Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Neutral
Business Wire
1 month ago
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call
DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 6, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 I.
Positive
Seeking Alpha
1 month ago
Enhabit: Healthcare Predictive Analytics, FCF, Very Undervalued
EHAB's investments in healthcare predictive analytics, expected to grow at 23%-24% CAGR, could significantly boost future net income growth. Restructuring, activism, and strategic reviews are potential catalysts for stock price appreciation, enhancing financial flexibility from 2025 to 2030. Despite recent negative net income, EHAB's consistent positive cash flow and undervaluation indicate substantial upside potential in stock price.
Charts implemented using Lightweight Charts™